BBAS3:BMFBOVESPABanco do Brasil S.A. Analysis
Data as of 2026-07-29 - not real-time
ARS 3,250.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Current price of 3,250 sits just above the 20‑day (3,119.6) and 50‑day (3,036.7) SMAs and also exceeds the 200‑day SMA (3,208.5), indicating a short‑term bullish bias. The RSI of 60.6 shows momentum still on the upside without being overbought, and the MACD histogram (+13.86) with a bullish signal reinforces technical strength. However, trading volume is on a decreasing trend and 30‑day volatility is elevated at 37%, suggesting price swings could be sharp.
On the valuation side, the price‑to‑book of 0.34 is well below the industry norm, hinting at an undervalued balance sheet, yet the price‑to‑sales of 268× reflects weak revenue generation. Revenue has contracted 21.8% year‑over‑year, and the company does not pay a dividend, making dividend sustainability a non‑factor. With a beta near 1 and a max drawdown of 30%, the stock carries market‑level systematic risk and notable downside vulnerability.
On the valuation side, the price‑to‑book of 0.34 is well below the industry norm, hinting at an undervalued balance sheet, yet the price‑to‑sales of 268× reflects weak revenue generation. Revenue has contracted 21.8% year‑over‑year, and the company does not pay a dividend, making dividend sustainability a non‑factor. With a beta near 1 and a max drawdown of 30%, the stock carries market‑level systematic risk and notable downside vulnerability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term SMAs and bullish MACD
- Decreasing volume and high volatility
- Resistance near 3,347.5 limiting upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued price‑to‑book ratio
- Potential stabilization of revenue after sharp decline
- Banking sector fundamentals in Brazil
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong book value and state‑backed ownership
- Long‑run dividend initiation potential
- Strategic position in Brazil’s financial system
Key Metrics & Analysis
Financial Health
Revenue Growth-21.80%
Profit Margin20.42%
ROE9.22%
ROA0.70%
P/B Ratio0.3
Op. Cash FlowARS54.2B
Industry P/E17.9
Technical Analysis
TrendNeutral
RSI60.6
SupportARS 2,930.00
ResistanceARS 3,347.50
MA 20ARS 3,119.63
MA 50ARS 3,036.65
MA 200ARS 3,208.45
MACDBullish
VolumeDecreasing
Fear & Greed Index84.54
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.99
Volatility37.30%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.